You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Paraganglioma

Showing 1 - 25 of 89
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Anlotinib Treatment Response Using Contrast Enhanced Ultrasound

Recruiting
  • Pheochromocytoma, Metastatic
  • +3 more
  • Contrast-enhanced ultrasound(CEUS)
  • Beijing, China
    Peking Union Medical College Hospital
Aug 28, 2023

Pheochromocytoma, Metastatic, Paraganglioma, Malignant, Pheochromocytoma Malignant Trial in Beijing (Temozolomide capsule)

Completed
  • Pheochromocytoma, Metastatic
  • +2 more
  • Temozolomide capsule
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
May 4, 2023

F-18 FDOPA PET/CT Versus I-123 MIBG Scintigraphy With SPECT/CT

Terminated
  • Pheochromocytoma
  • Paraganglioma
  • F-18 FDOPA PET/CT
  • Seoul, Songpa-gu, Korea, Republic of
    Asan Medical Center
Jul 13, 2023

Pheochromocytoma, Metastatic, Pheochromocytoma Malignant, Paraganglioma, Malignant Trial in Beijing (Penpulimab)

Recruiting
  • Pheochromocytoma, Metastatic
  • +2 more
  • Beijing, China
    Peking Union Medical College Hospital
May 31, 2023

Bronchial and Thymic Neuroendocrine Tumour, Paraganglioma/ Phaeochromocytoma, Medullary Thyroid Carcinoma Trial (Lu-177 DOTATATE

Not yet recruiting
  • Bronchial and Thymic Neuroendocrine Tumour
  • +3 more
  • Lu-177 DOTATATE (Lutathera®)
  • (no location specified)
Nov 1, 2023

Pheochromocytoma, Paraganglioma, Neuroendocrine Tumors Trial run by the NCI (Lu-177-DOTATATE, Ga-68-DOTATATE, F-18-FDG)

Recruiting
  • Pheochromocytoma
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 19, 2023

PGL Trial in Beijing

Recruiting
  • PGL
    • Beijing, Beijing, China
      Peking Union Medical College Hospital,Chinese Academy of Medical
    Mar 6, 2023

    Head and Neck Paragangliomas: A 16-year Experience ofUniversity

    Enrolling by invitation
    • Head and Neck Paraganglioma
      • Denizli, Turkey
        Pamukkale University
      Jul 11, 2023

      Pheochromocytoma, Paraganglioma Trial in Philadelphia ([18F]FluorThanatrace ([18F]FTT))

      Not yet recruiting
      • Pheochromocytoma
      • Paraganglioma
      • [18F]FluorThanatrace ([18F]FTT)
      • Philadelphia, Pennsylvania
        Abramson Cancer Center of the University of Pennsylvania
      Dec 1, 2022

      Paraganglioma, Pheochromocytoma Trial in New York, Cleveland (Lanreotide)

      Recruiting
      • Paraganglioma
      • Pheochromocytoma
      • New York, New York
      • +1 more
      Oct 5, 2022

      Pheochromocytoma, Paraganglioma Trial in New York (Axitinib)

      Recruiting
      • Pheochromocytoma
      • Paraganglioma
      • New York, New York
        Columbia University Irving Medical Center
      Oct 5, 2022

      Pheochromocytoma, Paraganglioma Trial in Beijing (Temozolomide)

      Recruiting
      • Pheochromocytoma
      • Paraganglioma
      • Beijing, China
        Peking Union Medical College Hospital
      May 22, 2023

      Pheochromocytoma, Paraganglioma Trial in Beijing (Anlotinib HCl)

      Recruiting
      • Pheochromocytoma
      • Paraganglioma
      • Anlotinib hydrochloride
      • Beijing, China
        Peking Union Medical College Hospital
      May 22, 2023

      Dysglycemia in Pheochromocytoma and Paraganglioma

      Active, not recruiting
      • Pheochromocytoma
      • Paraganglioma
      • Catecholamines
      • Beijing, Beijing, China
        Xian-Liang Zhou
      Jul 9, 2022

      Malignant Adrenal Gland Pheochromocytoma, Malignant Paraganglioma, Metastatic Adrenal Gland Pheochromocytoma Trial in Rochester

      Completed
      Has Results
      • Malignant Adrenal Gland Pheochromocytoma
      • +2 more
      • Laboratory Biomarker Analysis
      • +2 more
      • Rochester, Minnesota
        Mayo Clinic
      Sep 28, 2022

      Malignant Adrenal Gland Pheochromocytoma, Malignant Paraganglioma, Pheochromocytoma, Metastatic Trial in Beijing (anlotinib HCl)

      Recruiting
      • Malignant Adrenal Gland Pheochromocytoma
      • +4 more
      • anlotinib hydrochloride
      • Beijing, Beijing, China
        Peking Union Medical College Hospital
      Apr 26, 2022

      Fluorescence Guided Minimally-Invasive Resection Of Abdominal

      Recruiting
      • Paraganglioma
      • Fluorescence guided identification using indocyanine green
      • Leiden, Netherlands
        Leiden University Medical Center
      Dec 1, 2023

      Neuroendocrine Tumors, Paraganglioma, Pheochromocytoma Trial (177Lu-DOTATOC)

      Not yet recruiting
      • Neuroendocrine Tumors
      • +2 more
      • (no location specified)
      Sep 13, 2023

      Pheochromocytoma, Paraganglioma Trial in Marseille (Infrared themrography)

      Recruiting
      • Pheochromocytoma
      • Paraganglioma
      • Infrared themrography
      • Marseille, Paca, France
        Pôle ENDO- Hopital la Conception APHM
      Nov 12, 2022

      Pheochromocytoma, Paraganglioma, Cardiovascular Morbidity Trial in Lucknow (Observational study)

      Completed
      • Pheochromocytoma
      • +2 more
      • Observational study
      • Lucknow, Uttar Pradesh, India
        Sanjay Gandhi Postgraduate Institute of Medical Sciences
      Feb 9, 2022

      Pheochromocytoma, Paraganglioma, Adrenalectomy; Status Trial in Seoul (Phenoxybenzamine)

      Recruiting
      • Pheochromocytoma
      • +3 more
      • Seoul, Korea, Republic of
        Seoul National University Hospital
      Jan 18, 2023

      Pheochromocytoma, Paraganglioma, Inherited Cancer Syndrome Trial in San Antonio (Genetic screening)

      Recruiting
      • Pheochromocytoma
      • +7 more
      • Genetic screening
      • San Antonio, Texas
        University of Texas Health Science Center
      Aug 25, 2022

      Development ofTele-monitoring Program for Patients Undergoing

      Recruiting
      • Pheochromocytoma
      • Paraganglioma
      • Use of an internet plateform
      • Paris, France
        Hopital européen Georges Pompidou
      Jan 17, 2022

      Exendin PET/CT for Imaging of Paragangliomas

      Recruiting
      • Paraganglioma
      • 68Ga-NODAGA-exendin-4 PET/CT
      • Nijmegen, Netherlands
        Radboud University Medical Center
      Jun 13, 2022

      Advanced or Metastatic Paraganglioma/ Pheochromocytoma Trial in Nanjing (Anlotinib)

      Recruiting
      • Advanced or Metastatic Paraganglioma/ Pheochromocytoma
      • Nanjing, Jiangsu, China
        The First Affiliated Hospital of Nanjing Medical Univerity
      Nov 17, 2021